Showing 1431-1440 of 20878 results for "".
- MEK Inhibition Shows Promise in Aggressive EB-Linked Skin Cancershttps://reachmd.com/news/mek-inhibition-shows-promise-in-aggressive-eb-linked-skin-cancers/2485197/A transcriptome-driven drug repurposing strategy has identified selumetinib as a potential therapeutic candidate for aggressive squamous cell carcinomas (SCCs) arising in recessive dystrophic epidermolysis bullosa (RDEB). Resea
- Assessing Suicide Risk: The Role of Head Injuries in Clinical Practicehttps://reachmd.com/news/assessing-suicide-risk-the-role-of-head-injuries-in-clinical-practice/2485172/A UK population study found adults with documented head injury had about a 21% higher likelihood of subsequent suicide attempts than matched peers.
- The Rise of OXA-48-like Carbapenemase-Producing E. coli in Hungary: Genomic Insights and Clinical Implicationshttps://reachmd.com/news/the-rise-of-oxa-48-like-carbapenemase-producing-e-coli-in-hungary-genomic-insights-and-clinical-implications/2485187/OXA-48–like carbapenemase–producing Escherichia coli have emerged in Baranya County, Hungary, posing an immediate threat to acute-care settings. Hospitals should treat these isolates as a new local risk because they narrow available therapy options and have demonstrated potential fo
- Anticipated Advances in GLP-1 Receptor Agonists: Implications for Primary Carehttps://reachmd.com/news/anticipated-advances-in-glp-1-receptor-agonists-implications-for-primary-care/2485171/Oral semaglutide expands semaglutide access and will change how primary care clinicians frame conversations about convenience, tolerability, and adherence; trials report effectiveness comparable to injectable formulations.
- Cross-Population Insights into Alzheimer's Disease: The Role of ADAMTS2https://reachmd.com/news/cross-population-insights-into-alzheimers-disease-the-role-of-adamts2/2485174/A recent study reported increased expression of the ADAMTS2 gene in Alzheimer’s disease in both African American and European Amer
- Navigating Pregnancy-Associated Colorectal Cancer: Immunological Insights and Management Challengeshttps://reachmd.com/news/pregnancy-associated-colorectal-cancer/2485135/Epidemiologic signals show an increased frequency of pregnancy-associated colorectal cancer (CRC), driven in part by later maternal age and h
- Understanding the Impacts of ACA Subsidy Expiration on Marketplace Stability and Patient Carehttps://reachmd.com/news/understanding-the-impacts-of-aca-subsidy-expiration-on-marketplace-stability-and-patient-care/2485193/Enhanced premium tax credits expired for 2026, reducing marketplace affordability and increasing the number of patients with unstable or no insurance. Exchange enrollment fell to 15.6 million for 2026, down from roughly 16 million the prior year,
- Emerging Threats: Genomic Insights and Clinical Implications of Carbapenem-Resistant K. pneumoniaehttps://reachmd.com/news/emerging-threats-genomic-insights-and-clinical-implications-of-carbapenem-resistant-k-pneumoniae/2485176/A genomic analysis of 99 carbapenem-resistant Klebsiella pneumoniae isolates documents a shifting clonal landscape: ST11 remains dominant (63.6%, 63/99), while an emergent
- Bioactive Chitosan–dECM Composite Shows Preclinical Promise for Inflammatory Hair Losshttps://reachmd.com/news/bioactive-chitosandecm-composite-shows-preclinical-promise-for-inflammatory-hair-loss/2485093/A novel topical composite combining amine-activated carboxymethyl chitosan (aaCMC) and hydrolyzed decellularized extracellular matrix (h-dECM) demonstrated antioxidant, immunomodulatory, and regenerative effects in preclinical models of inflammatory scalp injury, according to new research publish
- Revolutionizing Tuberculosis Treatment: Emerging Inhalable and Nanoformulation Delivery Systemshttps://reachmd.com/news/revolutionizing-tuberculosis-treatment-emerging-inhalable-and-nanoformulation-delivery-systems/2485180/Inhalable aerosols and nanoformulation platforms now promise improved lung deposition and reduced systemic toxicity for pulmonary tuberculosis therapies.